GlassScriptPhysician profile
John Guido Esposito
NPI 1306293097
$24,062.24
in general payments reported to CMS, 2019-2025
13 companies · $2,972 in 2025
The $2,972 reported for 2025 was more than what 76% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,503 · 2020: $1,469 · 2021: $3,184 · 2022: $5,197 · 2023: $2,745 · 2024: $3,992 · 2025: $2,972.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $9,708.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $9,708.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $20,615.62 | 2019-2025 | Mako, Variax, T2 Alpha |
| Zimmer Biomet Holdings, INC. | $1,969.86 | 2019-2025 | Rosa, G7 |
| Davol INC. | $375.72 | 2023-2024 | Arista Ah Flexitip |
| Depuy Synthes Sales INC. | $257.69 | 2019-2025 | Na, Va-Lcp |
| Sanara Medtech INC. | $175.34 | 2025 | Celleraterx |
| Smith+Nephew, INC. | $167.30 | 2019-2021 | |
| My01 INC. | $141.13 | 2023 | My01 Continuous Compartmental Pressure Monitor |
| Innovation Technologies INC | $120.94 | 2024 | Irrisept |
| Illuminoss Medical, INC. | $74.68 | 2024 | |
| US Implant Solutions, LLC | $74.40 | 2024 | |
| Moximed, INC | $32.99 | 2025 | Misha Knee System, Small, Left |
| Bioventus LLC | $30.99 | 2024 | Durolane |
| Medical Device Business Services, INC. | $25.58 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Esposito listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.